![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
E Romeo, DL Cheney, I Zivkovic, E Costa and A Guidotti
Fidia-Georgetown Institute for the Neurosciences, Georgetown University Medical School, Washington, District of Columbia.
In rats trained to retain a passive avoidance response or to retrieve a learned task in the radial and water maze tests, a pretreatment with 2- hexyl-3-indoleacetamide (FGIN-1-27) (IC50 57 mumol/kg p.o.) or 4' chlorodiazepam (4'CD) (15 mumol/kg i.p.), two steroidogenic ligands at the mitochondria diazepam-binding inhibitor receptor complex (MDRC), antagonized the performance deficit elicited by dizocilpine (0.3 mumol/kg i.p.), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. The 1-(2-chlorophenyl)-N-methyl-N-(-1-methyl-propyl)-3- isoquinoline carboxamide (PK-11195), an antagonist at MDRC in vivo, failed to modify the disruptive effect of dizocilpine in the passive avoidance response but reversed the FGIN-1-27- or 4' CD-induced antagonism of dizocilpine behavioral actions. Pretreatment with pregnenolone sulfate (48 mumol/kg i.p.), 3 alpha, 21-dihydroxy-5 alpha- pregnan-20-one (THDOC) (15 mumol/kg i.v.) and 3 alpha-hydroxy-5 alpha- pregnan-20-one (allopregnanolone) (15 mumol/kg i.v.) also reduced the passive avoidance retention deficit elicited by dizocilpine. The (17- beta)-17-[[bis(1-methylethyl)amino[carbonyl]androstane-3,5-diene-3- carboxylic acid (SKF-105111), a 5 alpha-reductase inhibitor, blocked the antagonism of dizocilpine behavioral actions by pregnenolone sulfate or by FGIN-1-27 but not those caused by THDOC or allopregnanolone either in normal or adrenalectomized-castrated rats. Thus, it is inferred that the amnesic effect of dizocilpine is counteracted by FGIN-1-27, 4'CD and pregnenolone sulfate because of their ability to increase brain accumulation of allopregnanolone.
This article has been cited by other articles:
|
|
 |
|
  F di Michele, M Verdecchia, M Dorofeeva, L Costamagna, G Bernardi, P Curatolo, and E Romeo GABAA receptor active steroids are altered in epilepsy patients with tuberous sclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2003; 74(5): 667 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Strohle, E. Romeo, F. di Michele, A. Pasini, B. Hermann, G. Gajewsky, F. Holsboer, and R. Rupprecht Induced Panic Attacks Shift {gamma}-Aminobutyric Acid Type A Receptor Modulatory Neuroactive Steroid Composition in Patients With Panic Disorder: Preliminary Results Arch Gen Psychiatry, February 1, 2003; 60(2): 161 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Romeo, A. Ströhle, G. Spalletta, F. d. Michele, B. Hermann, F. Holsboer, A. Pasini, and R. Rupprecht Effects of Antidepressant Treatment on Neuroactive Steroids in Major Depression Am J Psychiatry, July 1, 1998; 155(7): 910 - 913. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Vallee, W. Mayo, M. Darnaudery, C. Corpechot, J. Young, M. Koehl, M. Le Moal, E.-E. Baulieu, P. Robel, and H. Simon Neurosteroids: Deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus PNAS, December 23, 1997; 94(26): 14865 - 14870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lancel, J. Faulhaber, T. Schiffelholz, E. Romeo, F. Di Michele, F. Holsboer, and R. Rupprecht Allopregnanolone Affects Sleep in a Benzodiazepine-Like Fashion J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1213 - 1218. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
